Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010 is a research paper published in JAMA Network Open (2023). On theSindex it has a DataRank of 0. It has been cited 99 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIA NIH HHS
Grant: R33 AG058738
NIA NIH HHS
Grant: R01 AG034676
National Institutes of Health
Grant: 5R33AG058738-05
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology Project
National Institutes of Health
Grant: 5R01AG034676-52
Multimorbidity and Aging: Rochester Epidemiology Project
FWCI
18.13
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients
Additional file 2 of Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients
Additional file 1 of Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients
Additional file 1 of Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients